A widely accepted model systematically underpredicts major atherosclerotic cardiovascular disease (ASCVD) risk in disadvantaged communities, according to a new study in Annals of Internal Medicine.

Patients with advanced renal dysfunction received no significant benefit from statin therapy following acute MI in a study of 861 individuals.

Researchers have found a distinctive reactionary pattern in the brain that could be used to identify individuals at greater risk for hypertension and cardiovascular disease (CVD) as a result of psychological stressors.

Federal statistics show college graduates live longer, healthier lives. People with higher educational attainment also have less lifetime risk of cardiovascular disease (CVD), according to a study in JAMA Internal Medicine.

When it comes to choosing whether to initiate statin treatment, similar clinical and economic consequences result if clinicians follow current guidelines or use coronary artery calcium (CAC) testing to guide that decision, according to new research.

Nearly nine in 10 patients with atherosclerotic cardiovascular disease (ASCVD) could improve their cholesterol levels with oral-only treatment, according to a new study.

Potentially modifiable midlife vascular risk factors could be associated with dementia later in life, according to a study.

A new study by researchers at Yale and Drexel Universities explores the heart health problems associated with incarceration, in populations including those currently in prison and the released.